Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Roche Diagnostics Australia Pty Limited
Class 3
Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany
CT929 - Acquired genetic alteration IVDs
IVDs that are intended to be used in genetic testing to provide information about acquired genetic alterations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information.
A
2012-02-03